Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.3400 (0.88%) ($10.1010 - $10.4300) on Tue. Feb. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.07% (three month average) | RSI | 38 | Latest Price | $10.3400(0.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(30%) IBB(27%) SDY(26%) IFRA(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.535% in a week (0% probabilities). VIXM(-15%) UUP(-9%) VXX(-7%) TLT(-1%) SMH(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.535% (StdDev 3.07%) | Hourly BBV | 1.1 () | Intraday Trend | 0.9% | | | |
|
Resistance Level | $10.48 | 5 Day Moving Average | $10.28(0.58%) | 10 Day Moving Average | $10.44(-0.96%) | 20 Day Moving Average | $10.48(-1.34%) | To recent high | -25% | To recent low | 3.5% | Market Cap | $1.824b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |